Birdwatch Note
2024-11-30 02:57:59 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
公開CN再掲です https://x.com/i/birdwatch/t/1851522359150166132 疑い報告は因果関係がわからない場合も報告対象で被害の事ではありません https://web.archive.org/web/20231209230117/https://www.mhlw.go.jp/content/10900000/000760489.pdf 専門家の医薬学的総合評価で https://www.info.pmda.go.jp/fsearchnew/jsp/causal.jsp 因果関係が否定できない事例は2例です。18p https://www.mhlw.go.jp/content/11120000/001321098.pdf#page=18 日本人の死亡の1-2割は突然死で http://www.jsomt.jp/journal/pdf/062010057.pdf 接種後死亡は接種による死亡を意味せず従来ワクチンでも日常的に発生し https://www.ajpmonline.org/article/S0749-3797(13)00225-0/fulltext 任意有害事象報告頻度は多様な要因の影響を受けCDCは実際の頻度評価には使えないと明示しています https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/vaers/index.html#:~:text=VAERS%20is%20the%20nation's%20early,make%20sure%20vaccines%20are%20safe. 実際、新型インフルワクチンでも同様の頻度の報告があり https://www.yakuji.co.jp/entry21054.html コロナワクチンでも22年の最初の4ロットは21年の最初の4ロットと比べ全副反応報告頻度は百分の１です(88p https://www.mhlw.go.jp/content/10601000/001161404.pdf#page=88
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1862682938296701052
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1862692524118482956
- noteId - 1862692524118482956
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1732935479560
- tweetId - 1862682938296701052
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 1
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 公開CN再掲です https://x.com/i/birdwatch/t/1851522359150166132 疑い報告は因果関係がわからない場合も報告対象で被害の事ではありません https://web.archive.org/web/20231209230117/https://www.mhlw.go.jp/content/10900000/000760489.pdf 専門家の医薬学的総合評価で https://www.info.pmda.go.jp/fsearchnew/jsp/causal.jsp 因果関係が否定できない事例は2例です。18p https://www.mhlw.go.jp/content/11120000/001321098.pdf#page=18 日本人の死亡の1-2割は突然死で http://www.jsomt.jp/journal/pdf/062010057.pdf 接種後死亡は接種による死亡を意味せず従来ワクチンでも日常的に発生し https://www.ajpmonline.org/article/S0749-3797(13)00225-0/fulltext 任意有害事象報告頻度は多様な要因の影響を受けCDCは実際の頻度評価には使えないと明示しています https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/vaers/index.html#:~:text=VAERS%20is%20the%20nation's%20early,make%20sure%20vaccines%20are%20safe. 実際、新型インフルワクチンでも同様の頻度の報告があり https://www.yakuji.co.jp/entry21054.html コロナワクチンでも22年の最初の4ロットは21年の最初の4ロットと比べ全副反応報告頻度は百分の１です(88p https://www.mhlw.go.jp/content/10601000/001161404.pdf#page=88
Note Ratings
| rated at | rated by | |
| 2024-11-30 06:58:38 -0600 | Rating Details | |
| 2024-11-30 06:24:15 -0600 | Rating Details | |
| 2024-11-30 04:37:08 -0600 | Rating Details | |
| 2024-11-30 04:16:33 -0600 | Rating Details | |
| 2024-11-30 01:22:14 -0600 | Rating Details | |
| 2024-11-30 01:18:50 -0600 | Rating Details | |
| 2024-11-30 01:06:34 -0600 | Rating Details | |
| 2024-11-30 00:36:03 -0600 | Rating Details | |
| 2024-11-30 00:26:52 -0600 | Rating Details | |
| 2024-11-29 22:30:42 -0600 | Rating Details | |
| 2024-11-29 22:26:35 -0600 | Rating Details | |
| 2024-11-29 22:22:05 -0600 | Rating Details | |
| 2024-11-29 22:21:41 -0600 | Rating Details | |
| 2024-11-29 22:11:30 -0600 | Rating Details | |
| 2024-11-29 22:10:35 -0600 | Rating Details | |
| 2024-11-29 21:55:58 -0600 | Rating Details | |
| 2024-11-29 21:54:52 -0600 | Rating Details | |
| 2024-11-30 06:26:08 -0600 | Rating Details | |
| 2024-11-30 03:41:17 -0600 | Rating Details | |
| 2024-11-30 02:43:39 -0600 | Rating Details | |
| 2024-11-30 01:34:32 -0600 | Rating Details | |
| 2024-11-30 01:18:46 -0600 | Rating Details | |
| 2024-11-29 23:53:05 -0600 | Rating Details | |
| 2024-11-29 23:17:04 -0600 | Rating Details | |
| 2024-11-29 23:06:18 -0600 | Rating Details | |
| 2024-11-29 22:18:07 -0600 | Rating Details | |
| 2024-11-29 22:14:24 -0600 | Rating Details | |
| 2024-11-29 22:00:21 -0600 | Rating Details | |
| 2024-11-29 21:43:05 -0600 | Rating Details | |
| 2024-11-29 21:20:12 -0600 | Rating Details | |
| 2024-11-30 09:06:20 -0600 | Rating Details | |
| 2024-11-30 02:36:44 -0600 | Rating Details | |
| 2024-11-29 23:33:05 -0600 | Rating Details | |
| 2024-11-29 21:43:26 -0600 | Rating Details | |
| 2024-11-29 21:15:56 -0600 | Rating Details | |
| 2024-11-29 21:07:09 -0600 | Rating Details |